B · Normal
[The concept of innovative drugs fluctuated and rebounded, Berry Genetics hit the daily limit] On October 15th, the concept of innovative drugs fluctuated and rebounded, Berry Genetics hit the daily limit, Jinshi Yao, Sanyuan Gene, North China Pharmaceutical, Aosaikang, and Guangshengtang followed suit. According to the news, on October 13, the National Medical Insurance Administration held a meeting, which required that medical technology innovation be actively supported. Explore the establishment of a pre-project establishment system for medical service prices, and support more new medical technologies and new products to accelerate their entry into clinical large-scale application.
Live broadcast 🕐 2026-10-15 09:38

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet